Xulane Approval History
- FDA approved: Yes (First approved April 16th, 2014)
- Brand name: Xulane
- Generic name: ethinyl estradiol and norelgestromin
- Dosage form: Transdermal System
- Company: Mylan Pharmaceuticals Inc.
- Treatment for: Birth Control
Xulane (ethinyl estradiol and norelgestromin transermal system) is a generic version of Ortho Evra, a birth control patch used to prevent pregnancy.
Development History and FDA Approval Process for Xulane
|Apr 18, 2014||Mylan Launches Xulane - First Generic Ortho Evra Patch|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.